Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Simplified Proteomics Method Could Open the Door Toward Precision Medicine

Simplified Proteomics Method Could Open the Door Toward Precision Medicine

Epitope Binning-Seq: Revolutionizing Antibody Drug Discovery

Epitope Binning-Seq: Revolutionizing Antibody Drug Discovery

CARA Benchmark Set to Revolutionize Data-Driven Drug Discovery Methods

CARA Benchmark Set to Revolutionize Data-Driven Drug Discovery Methods

Peptidomimetics Unlock New Potential in Drug Discovery

Peptidomimetics Unlock New Potential in Drug Discovery

Brain Organoids Emerge as Powerful Tool for Drug Discovery in Mitochondrial Disease

Brain Organoids Emerge as Powerful Tool for Drug Discovery in Mitochondrial Disease

Secarna and Orbit Discovery Partner to Develop Next-Generation Targeted ASO Therapeutics

Secarna and Orbit Discovery Partner to Develop Next-Generation Targeted ASO Therapeutics

Integrative genomic study identifies two new potential drug targets in Mycobacterium tuberculosis

Integrative genomic study identifies two new potential drug targets in Mycobacterium tuberculosis

Mapping Neurodevelopmental Disease with High-Throughput In Vivo Perturb-seq

Mapping Neurodevelopmental Disease with High-Throughput In Vivo Perturb-seq

Sartorius Expands Collaboration with NVIDIA to Advance AI-Powered Drug Discovery

Sartorius Expands Collaboration with NVIDIA to Advance AI-Powered Drug Discovery

Syntekabio to Unveil Novel Biologics Platform at 20th Annual PEGS Boston Summit

Syntekabio to Unveil Novel Biologics Platform at 20th Annual PEGS Boston Summit

New AI Platform Generates Multi-Target Cancer Drug Candidates

New AI Platform Generates Multi-Target Cancer Drug Candidates

Epigenomic Analysis Reveals Potential Treatment Avenues for ALS

Epigenomic Analysis Reveals Potential Treatment Avenues for ALS

Mapping Small Molecule-Protein Interactions for Drug Development

Mapping Small Molecule-Protein Interactions for Drug Development

Enhancing Drug Discovery Through Automated Protein Labeling

Enhancing Drug Discovery Through Automated Protein Labeling

Unveiling Cannabinoid’s Potential for Treating Age-Related Brain Degeneration

Unveiling Cannabinoid’s Potential for Treating Age-Related Brain Degeneration

Unlocking Bacterial Dormancy: Polyphosphates' Role Revealed

Unlocking Bacterial Dormancy: Polyphosphates' Role Revealed

Designing Compounds for Next-Gen Antibiotics and Cancer Treatments

Designing Compounds for Next-Gen Antibiotics and Cancer Treatments

Study Reveals Structure of Two Nucleic Acid-Degrading Enzymes

Study Reveals Structure of Two Nucleic Acid-Degrading Enzymes

Unveiling the Potential of the New Antibiotics Against Bacteria

Unveiling the Potential of the New Antibiotics Against Bacteria

Groundbreaking AI Framework Revolutionizes Drug Discovery

Groundbreaking AI Framework Revolutionizes Drug Discovery

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.